Loading...
Loading...
Comprehensive Guide
Forget total cholesterol. The real markers that predict heart disease are apoB, Lp(a), LDL particle count, and triglyceride-to-HDL ratio. This guide covers the advanced testing, evidence-based supplements, dietary strategies, and protocols to optimize your lipid profile from the ground up.
The Problem
The standard lipid panel — total cholesterol, LDL-C, HDL-C, triglycerides — was designed in the 1970s. It measures cholesterol mass, not particle count. This distinction is the reason 50% of heart attack victims have 'normal' cholesterol.
Imagine two highways. Highway A has 50 large trucks carrying cargo. Highway B has 200 small cars carrying the same total cargo. Both highways transport the same mass of goods, but Highway B has 4x more vehicles. In cardiovascular disease, it is the number of vehicles (LDL particles) — not the cargo (cholesterol mass) — that determines risk. Each particle that penetrates the arterial wall is an opportunity for atherosclerosis. This is why apoB (which counts particles) outperforms LDL-C (which measures cargo) as a risk predictor.
When LDL-C and LDL particle number (LDL-P) disagree — a phenomenon called discordance that occurs in ~20% of people — cardiovascular risk tracks with particle number, not cholesterol mass. You could have a "normal" LDL-C of 100 mg/dL but a dangerously high LDL-P of 1,600 nmol/L.
Standard Panel (insufficient)
Advanced Panel (recommended)
Know Your Numbers
These are the markers that actually predict cardiovascular events. Standard lipid panels miss most of them. Request these by name from your doctor or order through direct-to-consumer lab services.
Apolipoprotein B
The total number of atherogenic lipoprotein particles in your blood. One apoB molecule sits on each LDL, VLDL, IDL, and Lp(a) particle. Directly counts the 'vehicles' that deliver cholesterol into artery walls.
Standard Range
< 130 mg/dL
Optimal Range
< 80 mg/dL (ideally < 60 mg/dL for high-risk individuals)
Two people with the same LDL-C can have vastly different particle counts. ApoB captures what LDL-C misses — it is the single best predictor of cardiovascular events. The European Atherosclerosis Society now recommends apoB as a primary target.
Lipoprotein(a)
A genetically determined lipoprotein particle with an additional apolipoprotein(a) protein attached to LDL. Independently promotes atherosclerosis, thrombosis, and aortic valve calcification.
Standard Range
< 75 nmol/L or < 30 mg/dL
Optimal Range
< 50 nmol/L or < 20 mg/dL
Affects ~20% of the population and is an independent risk factor not captured by standard lipid panels. Largely genetically fixed — you only need to test once. If elevated, it changes your entire risk management strategy.
LDL-P (via NMR Lipoprofile)
The actual count of LDL particles per liter of blood, measured by nuclear magnetic resonance spectroscopy. Distinguishes between having few large particles (lower risk) versus many small particles (higher risk).
Standard Range
< 1,300 nmol/L
Optimal Range
< 1,000 nmol/L
LDL-C can be misleadingly 'normal' while LDL-P is dangerously elevated — a pattern called discordance. When LDL-C and LDL-P disagree, cardiovascular risk tracks with particle number, not cholesterol mass.
Small Dense LDL vs Large Buoyant LDL
The size distribution of your LDL particles. Pattern A (predominantly large buoyant particles) is associated with lower risk. Pattern B (predominantly small dense particles) carries 3x the cardiovascular risk.
Standard Range
Pattern A (large buoyant predominance)
Optimal Range
Pattern A with minimal small dense LDL
Small dense LDL particles are more atherogenic because they penetrate the arterial endothelium more easily, are more susceptible to oxidation, and have a longer circulating half-life. High triglycerides and insulin resistance drive Pattern B.
Serum Triglycerides (fasting)
Fat molecules (glycerol + three fatty acid chains) circulating in your blood, primarily carried by VLDL particles. Reflects dietary carbohydrate and sugar intake more than dietary fat intake.
Standard Range
< 150 mg/dL
Optimal Range
< 70 mg/dL
Elevated triglycerides drive production of small dense LDL, lower HDL, and are a hallmark of insulin resistance and metabolic syndrome. The triglyceride-to-HDL ratio is one of the best surrogate markers for cardiovascular risk.
High-Density Lipoprotein Cholesterol
Cholesterol carried by HDL particles, which perform reverse cholesterol transport — removing cholesterol from artery walls and returning it to the liver for excretion. HDL also has anti-inflammatory, antioxidant, and endothelial-protective functions.
Standard Range
> 40 mg/dL (men), > 50 mg/dL (women)
Optimal Range
> 60 mg/dL with good functionality
HDL quantity alone is incomplete — drugs that raised HDL (like torcetrapib) failed to reduce cardiovascular events. HDL function (cholesterol efflux capacity) matters more than the number. Exercise, olive oil, and moderate alcohol improve both HDL quantity and function.
Coronary Artery Calcium Score
A non-contrast CT scan that directly quantifies calcified plaque in your coronary arteries. Expressed in Agatston units. Provides a direct measurement of existing atherosclerotic disease — not a prediction, but actual plaque.
Standard Range
0 (zero plaque detected)
Optimal Range
0 — and maintain it
A CAC of zero reclassifies 'high-risk' individuals into very low risk (10-year event rate below 1-2%). A CAC above 100 significantly increases risk regardless of lipid levels. This test changes clinical decision-making more than any blood marker. Recommended after age 40 for intermediate-risk individuals.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
Myths Debunked
Decades of oversimplified public health messaging have created deeply entrenched myths about cholesterol. Here is what the current evidence actually shows.
Reality: For ~75% of people (hypo-responders), dietary cholesterol has minimal impact on blood levels. The liver produces 80% of circulating cholesterol and adjusts production based on intake. The remaining ~25% (hyper-responders) do see increases, primarily in large buoyant LDL — the less atherogenic subtype. The 2020 Dietary Guidelines removed the daily cholesterol limit. Eggs, once demonized, are now considered a nutritious whole food.
Reality: LDL is a heterogeneous class of particles ranging from large buoyant (Pattern A) to small dense (Pattern B). Large buoyant LDL is relatively benign — it is too big to easily penetrate the arterial endothelium and is less susceptible to oxidation. Small dense LDL is the truly atherogenic subtype: it penetrates artery walls, gets oxidized, and triggers foam cell formation. A standard LDL-C measurement does not distinguish between these patterns. ApoB and NMR lipoprofile do.
Reality: The low-fat era (1980s-2000s) replaced dietary fat with refined carbohydrates, leading to epidemics of obesity, insulin resistance, and metabolic syndrome — all of which worsen cardiovascular risk. The PREDIMED trial demonstrated that a high-fat Mediterranean diet (supplemented with EVOO or nuts) reduced cardiovascular events by 30% compared to a low-fat diet. Total fat intake matters less than fat quality: monounsaturated (olive oil) and omega-3 (fatty fish) fats improve lipid profiles, while trans fats and excessive omega-6 seed oils worsen them.
Reality: Total cholesterol is a crude and outdated metric. It combines LDL, HDL, VLDL, and Lp(a) into a single number — lumping protective (HDL) with atherogenic particles. A person with high HDL of 80 and low LDL of 110 will have 'high' total cholesterol of 190+ but excellent cardiovascular risk. Conversely, someone with low HDL, high triglycerides, and borderline LDL may have 'normal' total cholesterol but terrible metabolic health. ApoB, triglyceride-to-HDL ratio, and LDL particle number are far more informative.
Reality: Statins are highly effective and remain the gold standard for people with established cardiovascular disease or familial hypercholesterolemia. However, for primary prevention in intermediate-risk individuals, lifestyle changes (Mediterranean diet, exercise, weight loss) combined with targeted supplementation (berberine, bergamot, plant sterols, omega-3, psyllium) can achieve 25-40% LDL reductions — comparable to moderate-dose statins. The decision should be individualized based on your apoB level, CAC score, Lp(a), family history, and overall risk profile.
The Nuance
Not all saturated fats are created equal. The blanket recommendation to 'reduce saturated fat' ignores the fact that different saturated fatty acids have dramatically different effects on cholesterol.
Found in: Palm oil, butter, cheese, red meat
Raises LDL-C the most of any saturated fatty acid. Increases hepatic VLDL production and may impair LDL receptor function. The primary driver of the saturated-fat-raises-cholesterol effect.
Found in: Dark chocolate, beef fat, shea butter
Neutral effect on LDL-C. Rapidly converted to oleic acid (monounsaturated) by the liver enzyme stearoyl-CoA desaturase. This is why dark chocolate does not raise cholesterol despite being high in saturated fat.
Found in: Coconut oil, palm kernel oil
Raises both LDL and HDL, with the HDL increase proportionally greater. Net effect on cardiovascular risk is debated. Coconut oil is not the villain it was portrayed as, but it is not a health food either — use in moderation.
Found in: Butter, coconut oil, dairy fat
Raises LDL-C moderately. The most potent cholesterol-raising saturated fatty acid per gram consumed. Found in smaller quantities than palmitic acid in most diets.
Replace excessive saturated fat (especially palmitic acid from processed foods) with monounsaturated fat (olive oil, avocados) and omega-3 polyunsaturated fat (fatty fish). Do not replace saturated fat with refined carbohydrates — this worsens cardiovascular risk. Moderate saturated fat from whole-food sources (eggs, dark chocolate, grass-fed dairy) is acceptable within a Mediterranean-style dietary pattern. Your individual response depends heavily on APOE genotype: APOE4 carriers are more sensitive to saturated fat and should be more cautious.
Nutrition Strategy
The Mediterranean diet is the most evidence-backed dietary pattern for cardiovascular health. These are the specific foods — and mechanisms — that move the needle on your lipid panel.
Reduces LDL oxidation, improves HDL function, anti-inflammatory oleocanthal
Monounsaturated oleic acid replaces saturated fat in cell membranes, improving LDL receptor function. Polyphenols (hydroxytyrosol, oleocanthal) prevent LDL oxidation — oxidized LDL is what actually penetrates artery walls. The PREDIMED trial showed a 30% reduction in cardiovascular events with EVOO supplementation.
Lowers triglycerides 15-45%, anti-inflammatory EPA/DHA, improves HDL function
EPA and DHA reduce hepatic VLDL secretion (lowering triglycerides), shift LDL particles from small dense to large buoyant, produce anti-inflammatory resolvins and protectins, and stabilize vulnerable atherosclerotic plaques. SMASH fish (salmon, mackerel, anchovies, sardines, herring) provide the highest omega-3 content.
Reduces LDL by 5-10%, improves particle size, anti-inflammatory
Rich in monounsaturated fat, plant sterols, fiber, and L-arginine (precursor to nitric oxide for vascular health). Portfolio diet studies show almonds contribute a 5-7% LDL reduction. Walnuts provide alpha-linolenic acid (plant omega-3). Pistachios specifically improve LDL particle size distribution.
Reduces LDL by 5-10%, improves gut microbiome
Beta-glucan is a viscous soluble fiber that forms a gel in the intestine, trapping bile acids and cholesterol, preventing reabsorption. The liver must then pull LDL cholesterol from the blood to synthesize replacement bile acids. Also feeds beneficial gut bacteria that produce butyrate, supporting gut barrier integrity.
Reduces LDL by 5-8%, improves glycemic control, high in soluble fiber
Excellent source of soluble fiber, plant protein, and resistant starch. A 2014 meta-analysis in the Canadian Medical Association Journal found that one daily serving of legumes reduced LDL by 5% over 6 weeks. Also improves insulin sensitivity by slowing glucose absorption and feeding beneficial gut bacteria.
Reduces cholesterol absorption, provides vitamin K2 precursors, anti-inflammatory
Rich in lutein (which prevents LDL oxidation), nitrates (which improve endothelial function and nitric oxide production), folate (which lowers homocysteine), and vitamin K1 (which the gut can convert to K2 for arterial calcium regulation). Also provides magnesium, which is required for proper lipid metabolism enzyme function.
Reduces LDL and small dense LDL, increases HDL, anti-inflammatory
A 2020 Penn State study found that eating one avocado daily for 5 weeks reduced small dense LDL particles significantly. Rich in monounsaturated fat (oleic acid), potassium, fiber, and phytosterols. The combination of healthy fat + fiber + sterols creates a triple mechanism for cholesterol improvement.
Eliminate or Reduce
Extremely high in omega-6 linoleic acid, which promotes LDL oxidation — the critical step in atherosclerosis. Skews the omega-6:omega-3 ratio from the ideal 1-3:1 toward 20:1+. Highly processed, often rancid. Found in virtually all restaurant and processed food. Replace with olive oil, avocado oil, and coconut oil.
Drives triglyceride production, insulin resistance, and small dense LDL particle formation. Fructose specifically is metabolized by the liver into triglycerides (de novo lipogenesis), directly raising VLDL production. Insulin resistance from chronic sugar intake impairs LDL receptor function. Sugar is a bigger driver of dyslipidemia than dietary fat.
High glycemic load causes insulin spikes that trigger hepatic VLDL production, raise triglycerides, lower HDL, and shift LDL particles toward the small dense pattern. The carbohydrate-insulin model of dyslipidemia explains why low-fat/high-carb diets of the 1990s worsened cardiovascular risk.
The most atherogenic fat. Raises LDL, lowers HDL, increases triglycerides, promotes inflammation, and impairs endothelial function simultaneously. Even small amounts (2% of calories) increase cardiovascular risk by 23%. Banned in many countries but still found in some processed foods and restaurant fryers. Always check labels.
While moderate alcohol (especially red wine) may raise HDL, excessive intake (more than 1-2 drinks daily) raises triglycerides dramatically, promotes hepatic fat accumulation, and damages the liver — the organ responsible for managing cholesterol metabolism. Binge drinking spikes triglycerides acutely.
The PREDIMED trial (7,447 participants, 4.8-year follow-up) demonstrated a 30% reduction in major cardiovascular events with a Mediterranean diet supplemented with extra virgin olive oil or nuts versus a low-fat control diet. This is the strongest dietary evidence in cardiology.
Core principles: abundant olive oil (4+ tablespoons daily), fatty fish 3-4x/week, nuts daily, legumes daily, colorful vegetables at every meal, moderate red wine (optional), whole grains over refined, herbs and spices over salt. Minimize: seed oils, refined sugar, processed meats, refined flour, ultra-processed foods. This pattern naturally optimizes every lipid marker simultaneously.
Natural Agents
These supplements have clinical trial evidence for meaningful lipid improvements. Evidence grades: A = multiple RCTs or meta-analyses, B = limited RCTs or strong observational data.
500 mg, 2-3x daily with meals
Activates AMP-activated protein kinase (AMPK), which upregulates LDL receptor expression on hepatocytes — pulling LDL particles out of the bloodstream. Also inhibits PCSK9 (the enzyme that degrades LDL receptors), improves insulin sensitivity, and lowers triglycerides. Meta-analysis of 27 RCTs shows LDL reduction of 20-25%, comparable to low-dose statins. Also reduces blood glucose by 15-20% in diabetics.
Take with meals — can cause GI upset on empty stomach. Inhibits CYP3A4 and CYP2D6 enzymes: check drug interactions carefully. Do not combine with metformin without medical supervision (additive blood sugar lowering). Cycle 8 weeks on, 2 weeks off. Dihydroberberine (DHB) form has 5x better absorption.
500-1,000 mg standardized extract daily
Contains unique flavonoids (brutieridin and melitidin) that inhibit HMG-CoA reductase — the same enzyme targeted by statins — along with ACAT (reduces cholesterol esterification) and CETP. Clinical trials show 20-30% LDL reduction, 20-40% triglyceride reduction, and 15-40% HDL increase. Also improves LDL particle size (shifts from small dense to large buoyant) and has anti-inflammatory effects via NF-kB inhibition.
Look for extracts standardized to 38-47% flavonoids. Bergamonte is the most-studied branded form. Best taken with a meal. Can be combined with berberine for synergistic effects. Quality varies significantly between brands — choose third-party tested products.
1,200-2,400 mg daily (providing 10-20 mg monacolin K)
Contains monacolin K, which is chemically identical to lovastatin — an HMG-CoA reductase inhibitor. Reduces LDL by 15-25% in clinical trials. Also contains other monacolins, sterols, and isoflavones that contribute additional lipid-lowering effects beyond monacolin K alone. The CCSPS trial (nearly 5,000 participants) showed a 45% reduction in major coronary events.
Because it contains a natural statin, it carries the same potential side effects: muscle pain, liver enzyme elevation, CoQ10 depletion. ALWAYS supplement with CoQ10 (100-200 mg/day) when using red yeast rice. Avoid if pregnant. Quality is critical — some products contain citrinin (a nephrotoxic mycotoxin). Choose brands with third-party citrinin testing. Treat as a statin and monitor liver enzymes.
2-3 g daily, divided with meals
Structurally similar to cholesterol, plant sterols and stanols compete with dietary and biliary cholesterol for absorption in the intestine. They physically displace cholesterol from mixed micelles, reducing cholesterol absorption by 30-50%. This triggers the liver to upregulate LDL receptors to compensate, pulling more LDL from the blood. Meta-analyses show consistent LDL reductions of 6-15%.
Take with meals containing fat for best absorption. Available as supplements or in fortified foods (spreads, orange juice). Effects plateau at 3 g/day — more does not help. Can reduce absorption of fat-soluble vitamins (A, D, E, K) slightly; monitor if taking long-term. FDA allows a heart health claim for foods containing plant sterols.
10-15 g soluble fiber daily (5-10 g from psyllium)
Soluble fiber binds bile acids in the intestine, forcing the liver to convert more cholesterol into bile acids — effectively removing cholesterol from circulation. Psyllium husk is the most studied form: 5-10 g/day reduces LDL by 5-10%. Also slows glucose absorption (lowering insulin spikes), feeds beneficial gut bacteria (producing anti-inflammatory short-chain fatty acids), and improves bowel regularity.
Start low (3 g/day) and increase gradually to avoid bloating and gas. Always take with plenty of water — psyllium expands dramatically. Can interfere with medication absorption: take medications 1 hour before or 2 hours after psyllium. Combine with other fiber sources: oat beta-glucan (3 g/day), ground flaxseed, and chia seeds.
2-4 g combined EPA+DHA daily (higher dose for triglyceride reduction)
At therapeutic doses (2-4 g/day), omega-3s reduce triglycerides by 15-45% by decreasing hepatic VLDL production and increasing VLDL clearance. EPA specifically has anti-inflammatory effects on arterial walls and reduces oxidized LDL. The REDUCE-IT trial showed that 4 g/day of icosapent ethyl (pure EPA) reduced cardiovascular events by 25% in statin-treated patients with elevated triglycerides.
Triglyceride form absorbs 70% better than ethyl ester. EPA-dominant formulations preferred for cardiovascular benefit. Take with a fat-containing meal. IFOS certified for purity. Primary benefit is triglyceride lowering — effect on LDL-C is minimal (may slightly raise LDL-C while shifting particle size to large buoyant). Pairs synergistically with berberine for comprehensive lipid optimization.
500-2,000 mg daily (titrate slowly from 250 mg)
The most potent HDL-raising agent available (increases HDL by 15-35%). Also lowers triglycerides by 20-30% and is the only supplement proven to reduce Lp(a) by 20-30%. Mechanism: inhibits hepatic diacylglycerol acyltransferase-2 (DGAT2), reducing VLDL production. Also reduces free fatty acid release from adipose tissue. Shifts LDL particle size from small dense to large buoyant.
Flushing (skin redness, warmth, tingling) is the most common side effect — harmless but uncomfortable. Minimize by starting low (250 mg), taking with food, and using extended-release forms. Take an aspirin or apple 30 minutes before if flushing is severe. Monitor liver enzymes and uric acid quarterly. DO NOT use sustained-release (SR) niacin — it causes liver toxicity. Extended-release (ER) and immediate-release (IR) forms are safer. Despite raising HDL, the AIM-HIGH and HPS2-THRIVE trials showed no cardiovascular benefit when added to statins — its standalone value is debated.
500-1,200 mg standardized extract daily
Contains luteolin and cynarin, which inhibit HMG-CoA reductase and increase bile acid excretion. Clinical trials show LDL reductions of 10-20% and modest improvements in HDL. Also has hepatoprotective effects and improves bile flow, supporting overall cholesterol metabolism. A 2018 meta-analysis of 9 RCTs confirmed significant reductions in total cholesterol, LDL, and triglycerides.
Well-tolerated with minimal side effects. Can cause increased gas or bloating initially. Avoid if you have bile duct obstruction or are allergic to plants in the Asteraceae family (ragweed, daisies, chrysanthemums). Effects are modest on their own but meaningful when stacked with other lipid-lowering agents. Take with meals.
Disclaimer: Supplements are not a replacement for medical treatment. Always consult your healthcare provider before starting a new supplement regimen, especially if you take medications (particularly statins, blood thinners, or diabetes drugs) or have existing conditions. The information here is educational, not prescriptive. See our full disclaimer.
The Science
Understanding PCSK9 explains how both statins and natural alternatives like berberine work at the molecular level.
PCSK9 (proprotein convertase subtilisin/kexin type 9) is an enzyme produced by the liver that degrades LDL receptors on the surface of hepatocytes. When PCSK9 attaches to an LDL receptor, the receptor is destroyed instead of recycled back to the cell surface. Fewer LDL receptors means fewer LDL particles are cleared from the blood, resulting in higher LDL-C and apoB levels.
PCSK9 inhibitors (evolocumab/Repatha, alirocumab/Praluent) are monoclonal antibodies that block PCSK9, allowing LDL receptors to be recycled and dramatically increasing LDL clearance. They reduce LDL-C by 50-60% and apoB by 40-50%. The FOURIER and ODYSSEY OUTCOMES trials demonstrated significant cardiovascular event reduction. Newer options include inclisiran (small interfering RNA given as a twice-yearly injection) that silences PCSK9 gene expression.
Berberine is the most evidence-backed natural PCSK9 inhibitor. It downregulates PCSK9 mRNA expression, preserving LDL receptor density on liver cells. This is one mechanism by which berberine achieves statin-like LDL reductions. Resistance exercise also transiently reduces PCSK9 levels. Lunasin (a soy-derived peptide) shows promise in early research for natural PCSK9 inhibition.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
Your Action Plan
Don't try everything at once. This 3-level protocol builds systematically. Start with Foundation for 4 weeks, then layer on Intermediate, then Advanced. Test at each transition.
Weeks 1-4 — Dietary overhaul & baseline testing
Diet alone can reduce LDL by 10-15% and triglycerides by 20-30%. The Mediterranean diet is the single most impactful intervention for comprehensive lipid improvement. Get your baseline labs before starting so you can measure the impact of each level.
Weeks 5-12 — Targeted supplementation & exercise
Berberine + bergamot + plant sterols + omega-3s can compound to produce a 30-40% total LDL reduction. Combined with exercise (which raises HDL, lowers triglycerides, and improves insulin sensitivity), this level addresses every major lipid marker simultaneously. Retest at 8-12 weeks.
Month 4+ — Full-spectrum optimization & advanced testing
At this level, you are deploying dietary, supplemental, exercise, and lifestyle interventions together for maximum synergy. Track apoB and triglyceride-to-HDL ratio as your primary success metrics. If apoB remains stubbornly elevated despite full protocol implementation, pharmaceutical options (statins, ezetimibe, PCSK9 inhibitors) should be discussed with a cardiologist.
The Evidence
The major studies that inform evidence-based lipid management.
Mediterranean diet + EVOO or nuts reduced major cardiovascular events by 30% vs. low-fat diet. 7,447 participants over 4.8 years. The strongest dietary intervention evidence in cardiology.
4 g/day icosapent ethyl (pure EPA omega-3) reduced cardiovascular events by 25% in statin-treated patients with elevated triglycerides. Established high-dose EPA as a meaningful add-on therapy.
PCSK9 inhibitor evolocumab reduced LDL-C by 59% and cardiovascular events by 15% in patients with established atherosclerotic disease. Proved that extreme LDL lowering is safe and beneficial.
Genetically determined apoB levels predict cardiovascular events more strongly than LDL-C, establishing apoB as the causal atherogenic marker. Led to European Atherosclerosis Society recommendation for apoB as a primary target.
Berberine reduced LDL-C by 20-25%, triglycerides by 22-36%, and total cholesterol by 15-20%. Effects comparable to low-dose statins. Also reduced fasting glucose and improved insulin sensitivity.
Xuezhikang (standardized red yeast rice) reduced major coronary events by 45% and total mortality by 33% in 4,870 patients with previous MI over 4.5 years. The strongest clinical outcomes data for any lipid-lowering supplement.
CAC score of zero associated with 10-year cardiovascular event rate below 1-2%. CAC provides incremental risk prediction beyond all traditional risk factors and blood markers. Changed clinical decision-making for intermediate-risk patients.
FAQ
Biomarkers
The 20 key metrics for healthspan, including all lipid markers with optimal ranges and testing protocols.
Inflammation
Chronic inflammation drives atherosclerosis. hs-CRP, anti-inflammatory nutrition, and protocols to resolve it.
Nutrition
Deep dive into macronutrients, micronutrients, meal timing, and building a Mediterranean plate.
This guide gives you the science. A CryoCove coach gives you the personalization — which supplements to stack, what to test, how to sequence your protocol based on your apoB, Lp(a), and metabolic profile, and ongoing accountability as your numbers improve.